Human alpha-1 Proteinase Inhibitor [EPC]

4243 reported adverse events

Drugs of this class: ALPHA.1-PROTEINASE INHIBITOR HUMAN ALPHA1-PROTEINASE INHIBITOR (HUMAN)

These side effects are most commonly reported by patients taking drugs of the Human alpha-1 Proteinase Inhibitor [EPC] class:

# Side effect Count
0 DYSPNOEA 657
1 PNEUMONIA 556
2 FATIGUE 480
3 HEADACHE 426
4 PRODUCT DOSE OMISSION ISSUE 419
5 DEATH 336
6 COUGH 327
7 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 300
8 MALAISE 273
9 COVID-19 241
See all common reactions for Human alpha-1 Proteinase Inhibitor [EPC]

Drugs of the Human alpha-1 Proteinase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALPHA-1 ANTITRYPSIN DEFICIENCY 17 0.1932
1 ADENOVIRAL HEPATITIS 11 0.0468
2 OXYGEN SATURATION ABNORMAL 62 0.0218
3 INFUSION SITE BRUISING 29 0.0134
4 INSURANCE ISSUE 190 0.0124
5 VEIN RUPTURE 19 0.0113
6 POOR VENOUS ACCESS 99 0.0096
7 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 12 0.0091
8 OBSTRUCTION 34 0.0085
9 INFUSION SITE EXTRAVASATION 44 0.0071
See all enriched reactions for Human alpha-1 Proteinase Inhibitor [EPC]